U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla

Reuters03-05

March 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bark, Fleetcor Technologies and Tesla, on Tuesday.

HIGHLIGHTS

* Bark Inc : Jefferies raises to buy from hold; raises PT to $1.9 from $1.54

* Fleetcor Technologies Inc : Baird raises to outperform rating

* Tesla Inc : RBC raises target price to $298 from $297

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Akero Therapeutics Inc : Evercore ISI raises target price to $50 from $36

* Akoya Biosciences Inc : JP Morgan cuts target price to $10 from $12

* Ameresco Inc : Piper Sandler cuts target price to $32 from $42

* Amphastar Pharmaceuticals Inc : JP Morgan initiates with overweight rating; PT $60

* Apellis Pharmaceuticals Inc : JP Morgan raises target price to $79 from $78

* Api Group Corp : JP Morgan raises target price to $35 from $31

* Avidity Biosciences Inc : Leerink Partners raises target price to $38 from $18

* Bark Inc : Jefferies raises to buy from hold; raises PT to $1.9 from $1.54

* Bluebird Bio Inc : HSBC cuts target price to $1.02 from $2.31

* C4 Therapeutics Inc : Jefferies raises target price to $14 from $11

* Cheniere Energy Partners LP : RBC cuts target price to $54 from $61

* Cogent Communications Holdings Inc : JP Morgan cuts target price to $73 from $74

* Costco Wholesale Corp : Oppenheimer raises target price to $805 from $760

* Fleetcor Technologies Inc : Baird raises target price to $330 from $325

* Fleetcor Technologies Inc : Baird raises to outperform rating

* Gitlab Inc : D.A. Davidson cuts target price to $65 from $75

* Gitlab Inc : TD Cowen cuts target price to $76 from $80

* Henry Schein Inc : JP Morgan raises target price to $88 from $82

* Hilton Grand Vacations Inc : Jefferies raises target price to $54 from $50

* Hims & Hers Health Inc : Jefferies raises target price to $17 from $12

* Installed Building Products Inc : D.A. Davidson initiates coverage with buy rating

* Installed Building Products Inc : D.A. Davidson initiates coverage with PT $275

* Metagenomi Inc : JP Morgan initiates coverage with overweight rating

* Metagenomi Inc : JP Morgan initiates coverage with price target $16

* Metagenomi Technologies Llc : Jefferies initiates with buy rating

* Metagenomi Technologies Llc : Jefferies initiates with price target $23

* Natera Inc : Stephens raises target price to $104 from $78

* Nuvalent Inc : JP Morgan raises target price to $98 from $68

* Paccar Inc : JP Morgan raises target price to $135 from $116

* Patterson Companies Inc : JP Morgan cuts target price to $30 from $31

* Paymentus Holdings Inc : JP Morgan raises target price to $19 from $17

* Pennant Group Inc : Stephens raises target price to $22 from $21

* Planet Fitness Inc : RBC raises target price to $80 from $74

* Privia Health Group Inc : JP Morgan cuts target price to $30 from $38

* Springworks Therapeutics Inc : JP Morgan raises target price to $75 from $74

* Squarespace Inc : Baird raises target price to $39 from $30

* Squarespace Inc : Baird raises to outperform rating

* Stitch Fix Inc : Canaccord Genuity cuts target price to $3.5 from $4

* Stitch Fix Inc : Piper Sandler cuts target price to $2.25 from $3

* Stitch Fix Inc : Wedbush cuts target price to $3 from $4

* Tesla Inc : RBC raises target price to $298 from $297

* Topbuild Corp : D.A. Davidson initiates coverage with buy rating; PT $470

* UnitedHealth Group Inc : Stephens cuts target price to $570 from $605

* Viant Technology Inc : Canaccord Genuity raises target price to $10 from $8

* WW Grainger Inc : Oppenheimer raises target price to $1125 from $1075

* Xponential Fitness Inc : Stifel raises target price to $20 from $18

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment